787 results on '"Mitchell, Duane A."'
Search Results
2. A Study of Generative Large Language Model for Medical Research and Healthcare
3. Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
4. GatorTron: A Large Clinical Language Model to Unlock Patient Information from Unstructured Electronic Health Records
5. RNA aggregates harness the danger response for potent cancer immunotherapy
6. Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen-presenting cells
7. Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions
8. Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank
9. Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma
10. Adeno-associated virus delivered CXCL9 sensitizes glioblastoma to anti-PD-1 immune checkpoint blockade
11. mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors
12. Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy.
13. Causes of Organizational Conflict
14. Reponses to Organizational Conflict
15. Blocking Immune Checkpoint—LAIR1: Disrupting the LAIR1—FXIII-A—Collagen Immunosuppressive Circuit for Enhanced Antitumor Therapeutics
16. Figure S4 from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
17. Data from Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain Metastases
18. A large language model for electronic health records
19. Contemporary RNA Therapeutics for Glioblastoma
20. Multimodal In Vivo Tracking of Chimeric Antigen Receptor T Cells in Preclinical Glioblastoma Models
21. The current landscape of immunotherapy for pediatric brain tumors
22. KR158 Spheres Harboring Slow-Cycling Cells Recapitulate High-Grade Glioma Features in an Immunocompetent System.
23. Developing a computable phenotype for glioblastoma.
24. Adoptive cell therapy for glioma
25. Contributors
26. CD70 CXCR2-Modified CAR T-Cells Against Acute Myeloid Leukemia
27. KR158 spheres harboring slow-cycling cells recapitulate GBM features in an immunocompetent system
28. Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma. Cancers 2023, 15, 3843
29. Developing a computable phenotype for glioblastoma
30. CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
31. Canine osteosarcoma checkpoint expression correlates with metastasis and T-cell infiltrate
32. Vaccine Therapies for Cancer: Then and Now
33. Nanoparticles as immunomodulators and translational agents in brain tumors
34. A vaccine for glioma
35. Precision therapeutic targets for COVID-19
36. Prioritization schema for immunotherapy clinical trials in glioblastoma
37. Disruption of KIF3A in patient-derived glioblastoma cells: effects on ciliogenesis, hedgehog sensitivity, and tumorigenesis
38. A study of generative large language model for medical research and healthcare
39. CXCL9 recombinant adeno-associated virus (AAV) virotherapy sensitizes glioblastoma (GBM) to anti-PD-1 immune checkpoint blockade
40. IMMU-14. SINGLE CELL RNASEQ OF PBMCS FROM NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
41. QOL-27. EXPLORING DYADIC CHANGES IN ANXIETY AND DEPRESSION SYMPTOMS FOR PRIMARY BRAIN TUMOR PATIENTS AND THEIR FAMILY CAREGIVERS
42. IMMU-33. PRECISION ANTIGEN-DIRECTED IMMUNOTHERAPY TREATMENT OF BRAIN TUMORS INCREASES TUMOR-INFILTRATING EFFECTOR LYMPHOCYTE RESPONSES
43. IMMU-36. PD-1KO HEMATOPOIETIC STEM CELLS RAPIDLY DIFFERENTIATE INTO GLIOMA-INFILTRATING EFFECTOR T-CELLS
44. IMMU-41. IMMUNOLOGICAL TARGETING OF SLOW-CYCLING CELLS TO PREVENT RECURRENCE IN GBM
45. EXTH-81. RE-EXPRESSION OF CXCL9 FOLLOWING ADENO-ASSOCIATED VIRUS (AAV) TRANSGENE DELIVERY TRANSFORMS THE IMMUNOLOGICAL LANDSCAPE OF GLIOBLASTOMA, SENSITIZING TUMORS TO PD-1 IMMUNE CHECKPOINT BLOCKADE (ICB)
46. BIOM-56. THE PRIVATE AND RECURRING ANTIGENIC PROFILE OF MOST AGGRESIVE PEDIATRIC BRAIN TUMORS
47. EXTH-07. NEOADJUVANT PD1 BLOCKADE ALTERS THE TUMOR MICROENVIRONMENT POST-SURGERY IN A PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
48. CNSC-30. CD4 T CELLS MEDIATED UPREGULATION OF CCL4 CHEMOKINE DRIVES GLIOBLASTOMA TUMOR MICROENVIRONMENT REPROGRAMMING FOLLOWING TREATMENT WITH A NOVEL MRNA VACCINE
49. CTIM-11. MRNA AGGREGATES ELICIT RAPID IMMUNOLOGIC RESPONSE AND PSEUDOPROGRESSION IN GLIOBLASTOMA PATIENTS
50. 269 CAR T cell production expands endogenous T cell repertoire recognizing additional tumor antigen(s)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.